Navigation Links
ERT Launches 'Centralized Cardiac Safety 2.0': A Revolutionary New Approach to ECG Management in Clinical Trials
Date:3/10/2010

PHILADELPHIA, March 10 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced the launch of Centralized Cardiac Safety 2.0, a portfolio of new solutions that enable a significant new approach to cardiac safety in clinical trials. These new solutions overcome many of the perceived barriers to centralizing all ECGs in clinical trials.  ERT's aim is to improve the science of cardiac safety while helping sponsors reduce overall costs with the adoption of a fully centralized approach.

ERT is an established leader in centralized ECG core lab services. ERT's Centralized Cardiac Safety 2.0 utilizes newly developed software technology, within its best in class EXPERT operating platform, which improves data quality, reduces the investigator workload and improves the overall user experience at the investigative site.  This technology enables the collection of real time, consistent, quality information easing site operations for all stakeholders and delivering better value to biopharmaceutical companies. The commercial value to sponsors and contract research organizations is derived principally from significant cost savings and more efficient operations across entire programs of drug development regardless of therapeutic area.

To further enable trial sponsors to take full advantage of the benefits offered by this centralized ECG model, innovative new instruments are necessary to provide improved accuracy, reliability, space efficiency and cost effectiveness. As part of our Centralized Cardiac Safety 2.0 solution, ERT has also introduced ELI-PC under exclusive license from Mortara Instrument.  This will substantially reduce the ECG equipment and systems interface costs associated with a centralized approach.  This small hand-held ECG collection device will make it easier for companies to adopt a centralized system as it interacts seamlessly and automatically with the central database, dramatically reducing both site workload and the volume of queries generated. This reduction in queries will accelerate trial timelines in the same way that EDC has improved the data collection process in clinical trials in recent years.

Integration of this new ECG machine into computer systems will enable key information, such as patient demographics, to be automatically downloaded before a trial, saving staff time and costs associated with trial set-up.  Utilization of this new technology incorporated with the process enhancements and reduced site and sponsor burden will result in significant and measurable cost savings as well as faster database lock times.

This new approach focusing on people, process and technology will make it easier for companies to adopt a centralized solution as it promises to deliver better science, lower sponsor costs and more convenience for all stakeholders. Dr. Michael McKelvey, President and CEO of ERT, comments, "We are extremely pleased to announce ERT's new Centralized Cardiac Safety 2.0 offering, which represents an innovative new approach for cardiac safety in clinical trials. The combination of better software, processes and this revolutionary new ELI-PC device makes it easier and less costly for trial sponsors to adopt an efficient, high quality, centralized model."

A more in-depth explanation of the Centralized Cardiac Safety 2.0 approach is available at www.ert.com/ecg.  

For further information on ERT and its technology and services, please email info@ert.com, call +1 215 972 0420 or visit www.ert.com.

For further press information, please contact Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, Email ert@scottpr.com.

About ERT

Based in Philadelphia, PA ERT (eResearchTechnology, Inc.) (www.ert.com) is a global provider of technology and services to the biopharmaceutical, medical device, and related industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

SOURCE ERT

Back to top

RELATED LINKS
http://www.ert.com

'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System
2. Blizzard, McCarthy & Nabers Launches ReglanJustice.com
3. ARKRAY USA Launches the YouChoose(TM) Wellness Program
4. Stryker Launches New Technologies and Celebrates a Major Clinical Milestone at The American Academy of Orthopaedic Surgeons Conference
5. Kendle Launches New Global Biostatistics Infrastructure
6. Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
7. Feintuch Communications Launches Integrated PR and IR Practice for Healthcare and Life Sciences Organizations
8. Pioneer(R) Surgical Technology, Inc. Launches Contact(R) Anterior Lumbar Plate March 1
9. Hexaware Launches HPower10 for the Healthcare Industry
10. TechniScan Launches 3-D Breast Ultrasound Clinical Study in Freiburg University
11. Thomson Reuters Launches Pharmacy Intervention Solution for Hospital Pharmacists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):